Sort
51,593 grants matching “hepatitis”
Nutrition, GI and Metabolism
$537,402Christine A Wanke · Miriam Hospital · P30 · FY2010 · AI
Brief intervention for drug-using rural women at high-risk for HIV/HCV
$537,382Michele Staton · University Of Kentucky · R01 · FY2015 · DA
NEUROBIOLOGY
$537,325Eliezer Masliah · University Of California, San Diego · P01 · FY2009 · DA
RNA modification in cardiometabolic disease
$537,319Tamer Sallam · University Of California Los Angeles · R01 · FY2024 · DK
Evaluation of therapeutic benefits of HBV nucleocapsid assembly inhibitors
$537,218Ju-Tao Guo · Baruch S. Blumberg Institute · R01 · FY2018 · AI
Novel strategies to accelerate repair of drug-induced hepatotoxicity
$537,217James P Luyendyk · Michigan State University · R01 · FY2024 · DK
A Clinical Trial to Prevent New Onset Diabetes After Transplantation
$537,073Akinlolu O Ojo · University Of Michigan At Ann Arbor · R01 · FY2011 · DK
Rational development of anti-Trypanosoma cruzi drugs
$537,055Frederick Simmons Buckner · University Of Washington · R01 · FY2011 · AI
Resistance to T cell exhaustion
$536,999Allan J Zajac · University Of Alabama At Birmingham · R01 · FY2021 · AI
Resistance to T cell exhaustion
$536,999Allan J Zajac · University Of Alabama At Birmingham · R01 · FY2025 · AI
Resistance to T cell exhaustion
$536,999Allan J Zajac · University Of Alabama At Birmingham · R01 · FY2024 · AI
Resistance to T cell exhaustion
$536,999Allan J Zajac · University Of Alabama At Birmingham · R01 · FY2023 · AI
Resistance to T cell exhaustion
$536,999Allan J Zajac · University Of Alabama At Birmingham · R01 · FY2022 · AI
The Lipin Protein Family and Triglyceride Metabolism
$536,992Karen Reue · University Of California Los Angeles · P01 · FY2017 · HL
Investigation of management and disease manifestations of viral hepatitis
$536,972Theo Heller · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2009 · DK
Investigation of non-cirrhotic portal hypertension.
$536,972Theo Heller · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2009 · DK
Maternal Obesity and Pediatric NAFLD: Fetal Origins and Long-term outcomes in Non Human Primates
$536,924Jacob E Friedman · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2024 · DK
Health systems innovations for supporting transitions of care for incarcerated people living with HIV, hepatitis C and opioid use disorder
$536,825Ryan Patrick Westergaard · University Of Wisconsin-Madison · R01 · FY2020 · DA
Gut microbiota mediated bile acid alterations in hepatic carcinogenesis
$536,813Wei Jia · University Of Hawaii At Manoa · U01 · FY2015 · CA
Determinants and Outcomes of Nicotine Metabolite Ratio in HIV + Smokers
$536,730Robert Gross · University Of Pennsylvania · R01 · FY2021 · HL
Midwest Hepatitis B Consortium
$536,665Adrian Michael Di Bisceglie · Saint Louis University · U01 · FY2014 · DK
MRI Assessment of Hip Fracture Risk and Therapy Response in HIV/HCV Coinfection
$536,630Chamith Sudesh Rajapakse · University Of Pennsylvania · R01 · FY2020 · AR
A systematic analysis of small RNA interactions during RNA virus infections
$536,595Charles M. Rice · Rockefeller University · R01 · FY2020 · AI
Metabolomic Assessment of Estrogenic Endocrine Disruptor
$536,571Timothy R Zacharewski · Michigan State University · R01 · FY2009 · ES
University of Washington/Fred Hutch Center for AIDS Research
$536,547Connie L Celum · University Of Washington · P30 · FY2024 · AI